7 News: How radiation oncologists are adapting treatment plans to keep patients safe during COVID-19

Our Chief Medical Officer for Oncology, Associate Professor Peter O’Brien, and our beautiful patient from St Vincent’s, Elise Sproll, sat down with 7NEWS Sydney to speak about some the ways we have adapted cancer treatments during COVID-19.

Receiving a cancer diagnosis during COVID-19 adds an extra layer of anxiety.

We want to reassure patients that vital cancer treatment is available, and we have implemented a number of measures to keep our patients and staff safe.

In suitable breast cancer patients, doctors are now adopting hypofractionation radiation therapy which involves the delivery of fewer, larger doses of radiation therapy, shortening the treatment course.

In addition to limiting the amount of time patients have to spend in hospitals and centres, GenesisCare has implemented a number of other precautionary measures, including risk assessment screening, increased cleaning rounds, temperature checking, infection control training refreshers for staff and limiting visitors.

Cancer patients receiving larger radiation doses to reduce coronavirus risk

The message has been clear; stay at home. But, for those undergoing cancer treatment, it's life or death.Doctors are now delivering fewer and larger doses of radiation therapy to reduce their risk of infection.www.7NEWS.com.au #Coronavirus #7NEWS

Posted by 7NEWS Sydney on Thursday, April 9, 2020

 

Related articles

NSW-first: Sydney man with prostate cancer first in state to receive innovative oncology treatment

Re-purposing blood-pressure medications could reduce prostate cancer recurrence rate

News Interview with Executive Manager of Cardiology and Interventional Cardiologist, Professor Stephen Worthley

21st Century Oncology to join Australia’s GenesisCare in a partnership to increase access to high quality cancer care in U.S. communities